Business
Medtronic reports first quarter fiscal 2026 financial results
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025.
About this update from Medtronic Plc.
[{"type":"text","content":"11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth","length":93,"tagName":"p","attribs":{}},{"type":"text","content":"GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025.","length":231,"tagName":"p"},{"type":"image","alt":"Medtronic reports first quarter fiscal 2026 financial results","displaySize":"","headline":null,"caption":"Medtronic reports first quarter fiscal 2026 financial results","className":"","disableSlideshowImg":false,"size":{"original":{"width":200,"height":113,"url":"https://media.zenfs.com/en/prnewswire.com/36eabbe35b68fc4095aa3c6aeeeec3b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Qv6bedHblugiD9qTtefJvQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTIwMztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/36eabbe35b68fc4095aa3c6aeeeec3b1","width":200,"height":113}},"href":"https://mma.prnewswire.com/media/2753194/Medtronic_FY26Q1_Presentation.pdf?p=original","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Key Highlights","length":14,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $8.6 billion, adjusted revenue of $8.5 billion, increased 8.4% as reported and 4.8% organic","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP diluted EPS of $0.81 increased 1%; non-GAAP diluted EPS of $1.26 increased 2%","length":82,"tagName":"p"}]},{"val":[{"type":"text","content":"Company raises FY26 EPS guidance; reiterates FY26 organic revenue growth guidance","length":81,"tagName":"p"}]},{"val":[{"type":"text","content":"Cardiac Ablation Solutions revenue increased nearly 50%, including 72% in the US, on strength of pulsed field ablation (PFA) products","length":133,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. Centers for Medicare & Medicaid Services (CMS) posted proposed National Coverage Determination (NCD) for the Symplicity Spyral™ system for hypertension; final NCD expected on or before October 8, 2025","length":209,"tagName":"p"}]},{"val":[{"type":"text","content":"Received CE Mark for LigaSure™ RAS vessel-sealing technology on Hugo™ robotic-assisted surgery (RAS) system","length":107,"tagName":"p"}]}],"tagName":"ul","bull...